Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Alexza Pharmaceuticals Inc. | f56407e10vq.htm |
EX-10.4 - EX-10.4 - Alexza Pharmaceuticals Inc. | f56407exv10w4.htm |
EX-31.1 - EX-31.1 - Alexza Pharmaceuticals Inc. | f56407exv31w1.htm |
EX-10.2 - EX-10.2 - Alexza Pharmaceuticals Inc. | f56407exv10w2.htm |
EX-10.5 - EX-10.5 - Alexza Pharmaceuticals Inc. | f56407exv10w5.htm |
EX-31.2 - EX-31.2 - Alexza Pharmaceuticals Inc. | f56407exv31w2.htm |
EX-10.1 - EX-10.1 - Alexza Pharmaceuticals Inc. | f56407exv10w1.htm |
EXHIBIT 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of
1934, as amended (the Exchange Act), and Section 1350 of Chapter 63 of Title 18 of the United
States Code (18 U.S.C. § 1350), Thomas B. King, President and Chief Executive Officer of Alexza
Pharmaceuticals, Inc. (the Company), and August J. Moretti, the Senior Vice President and Chief
Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
1. The Companys Quarterly Report on Form 10-Q for the period ended June 30, 2010, to which this
Certification is attached as Exhibit 32.1 (the Periodic Report), fully complies with the
requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2. The information contained in the Periodic Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 26th day of July
2010.
/s/ Thomas B. King
President and Chief Executive Officer |
/s/ August J. Moretti
Senior Vice President and Chief Financial Officer |
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not to be incorporated by reference into any filing of
Alexza Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities
Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q),
irrespective of any general incorporation language contained in such filing.